ERBB2 and non-small cell lung carcinoma: Moreover, high levels of EGFR suggest poor survival in non-small cell lung carcinoma (NSCLC) patients, whereas high coexpression of EGFR and Her2-neu (another member of the erbB receptor tyrosine kinase family) is associated with outright inferior survival [29].